Biologics Extremities Spine Bone Growth Products Market Size is Expected to Reach USD 1.81 Billion by 2033, Growing at a CAGR of 3.40%: Straits Research byTim AllenJanuary 23, 2025
Biologics Regulatory Top Stories Ventris Medical Receives 510(k) Clearance for Innovative Backpack® Bone Graft Containment System byJosh SandbergJanuary 9, 2025
Biologics Spine Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division byJosh SandbergJanuary 7, 2025
Biologics Regulatory FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions byJosh SandbergJanuary 6, 2025
Biologics Extremities Top Stories Kuros Biosciences Expands into Extremities Markets byTim AllenNovember 19, 2024
Biologics Regulatory Spine NovaBone Receives FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications byTim AllenNovember 13, 2024
Biologics Spine BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data byTim AllenNovember 13, 2024
Biologics Regulatory Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures byTim AllenNovember 12, 2024
Biologics Financial Orthobiologics Market Is Expected To Reach a Revenue Of USD 11.7 Bn By 2033, at 5.7% CAGR: Dimension Market Research byTim AllenNovember 11, 2024
Biologics Spine Theradaptive Announces Peer-Reviewed Publication in Spine of Preclinical Spinal Fusion Study of OsteoAdapt™ SP byTim AllenNovember 6, 2024